Opinion
Video
Author(s):
Mickey Bryson recounts how Kristine Kucera, PA-C, MPAS, DHS, introduced a new medication and shared trial data with him, empowering him to make an informed decision about trying the new treatment.
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Review Explores Abrocitinib’s Off-Label Uses
Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data